Literature DB >> 18685050

Platelet gel for the surgical treatment of onychocryptosis.

Antonio Córdoba-Fernandez1, Rafael Rayo-Rosado, José María Juarez-Jiménez.   

Abstract

BACKGROUND: The growth factors derived from platelets contained in platelet-rich plasma comprise a series of molecules that favor the production of collagen with the proliferation of fibroblasts and new blood vessels. These substances exert their effect on the cells, acting in all the stages of cicatrization, especially in hemostasis and early fibroplasia.
METHODS: Thirty-five patients (70 feet) were selected, operated on both sides for ingrown hallux nails, and subjected to two different experimental conditions in a crossover clinical trial with positive control of treatment. Two main variables were analyzed: on one side, the bleeding, according to three preestablished categories, and on the other, the mean time of cicatrization in days.
RESULTS: Significant differences (P < .001) were found between the two groups for bleeding. We observed that cicatrization time did not differ significantly between the two treatments.
CONCLUSION: The use of platelet gel for the treatment of onychocryptosis by single nonincisional matricectomy can guarantee good hemostasis, with a significant reduction in bleeding, but does not produce a clinically significant reduction in cicatrization time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685050     DOI: 10.7547/0980296

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  2 in total

1.  Hemostatic Efficacy of Absorbable Gelatin Sponges for Surgical Nail Matrixectomy after Phenolization-A Blinded Randomized Controlled Trial.

Authors:  Antonio Córdoba-Fernández; Adrián Lobo-Martín
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

2.  Effectiveness of Leukocyte and Platelet-Rich Fibrin versus Nitrofurazone on Nail Post-Surgery Bleeding and Wound Cicatrization Period Reductions: A Randomized Single Blinded Clinical Trial.

Authors:  Xavier Garrido-Castells; Ricardo Becerro-de-Bengoa-Vallejo; César Calvo-Lobo; Marta Elena Losa-Iglesias; Patricia Palomo-López; Emmanuel Navarro-Flores; Daniel López-López
Journal:  J Clin Med       Date:  2019-09-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.